Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 μg and fluticasone propionate 250 μg: Implications for establishing bioequivalence of inhaled products
2009 ◽
Vol 31
(2)
◽
pp. 370-385
◽
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 38
(12)
◽
pp. 1622-1626
◽
1999 ◽
Vol 82
(3)
◽
pp. 273-280
◽
1998 ◽
Vol 5
(1)
◽
pp. 86A-86A
2001 ◽
Vol 17
(6)
◽
pp. 272-277
◽
1998 ◽
Vol 31
(2)
◽
pp. 111A
2016 ◽
Vol 64
(S 01)
◽
Keyword(s):